LEADER 01394nam  2200457   450 
001 9910789501003321
005 20230807211118.0
010   $a1-910419-96-6
010   $a1-910419-95-8
035   $a(CKB)3440000000001032
035   $a(MiAaPQ)EBC5092548
035   $a(Au-PeEL)EBL5092548
035   $a(CaPaEBR)ebr11451433
035   $a(OCoLC)953863478
035   $a(EXLCZ)993440000000001032
100   $a20171109h20152015  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 00$aAdvances and challenges in the delivery of nucleic acid therapeutics$hVolume 2. /$feditors, Olivia Merkel, Mansoor Amiji
210  1$aLondon, England :$cFuture Science Ltd,$d2015.
210  4$dİ2015
215   $a1 online resource (129 pages) $cillustrations (some color)
311   $a1-910419-97-4 
320   $aIncludes bibliographical references.
606   $aAntisense nucleic acids
606   $aNucleic acids
615  0$aAntisense nucleic acids.
615  0$aNucleic acids.
676   $a572.8
702   $aMerkel$b Olivia
702   $aAmiji$b Mansoor
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910789501003321
996   $aAdvances and challenges in the delivery of nucleic acid therapeutics$93707835
997   $aUNINA